SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-009019
Filing Date
2024-03-22
Accepted
2024-03-22 19:46:23
Documents
1
Period of Report
2024-03-20

Document Format Files

Seq Description Document Type Size
1 form4-03222024_110316.html 4  
1 form4-03222024_110316.xml 4 8172
  Complete submission text file 0001415889-24-009019.txt   9616
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address
Ballal Rahul D. (Reporting) CIK: 0001805097 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 24776663